 | • レポートコード：QYR2104Z0827 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、バイオ医薬品CMOサービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤製造、バイオシミラー製造、その他）、用途別市場規模（臨床製造、商業製造、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオ医薬品CMOサービスの市場動向 ・企業の競争状況、市場シェア ・バイオ医薬品CMOサービスの種類別市場規模（生物製剤製造、バイオシミラー製造、その他） ・バイオ医薬品CMOサービスの用途別市場規模（臨床製造、商業製造、その他） ・バイオ医薬品CMOサービスの北米市場規模2016-2027（アメリカ、カナダ） ・バイオ医薬品CMOサービスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオ医薬品CMOサービスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオ医薬品CMOサービスの中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオ医薬品CMOサービスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lonza、Boehringer Ingelheim、AGC Biologics、Rentschler Biotechnologie、JRS Pharma、Catalent、Biomeva、Samsung BioLogics、AbbVie、Binex、WuXi Biologics、PRA Health Sciences、ProBioGen、KBI Biopharma） ・結論 |
Market Analysis and Insights: Global Biopharmaceutical CMO Services Market
The global Biopharmaceutical CMO Services market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical CMO Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical CMO Services market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical CMO Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical CMO Services market.
Global Biopharmaceutical CMO Services Scope and Market Size
Biopharmaceutical CMO Services market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical CMO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others
Segment by Application
Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Lonza
Boehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics Manufacturing
1.2.3 Biosimilars Manufacturing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Manufacturing
1.3.3 Commercial Manufacturing
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical CMO Services Market Perspective (2016-2027)
2.2 Biopharmaceutical CMO Services Growth Trends by Regions
2.2.1 Biopharmaceutical CMO Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceutical CMO Services Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceutical CMO Services Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceutical CMO Services Industry Dynamic
2.3.1 Biopharmaceutical CMO Services Market Trends
2.3.2 Biopharmaceutical CMO Services Market Drivers
2.3.3 Biopharmaceutical CMO Services Market Challenges
2.3.4 Biopharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO Services Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceutical CMO Services Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO Services Revenue
3.4 Global Biopharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO Services Revenue in 2020
3.5 Biopharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical CMO Services Breakdown Data by Type
4.1 Global Biopharmaceutical CMO Services Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2022-2027)
5 Biopharmaceutical CMO Services Breakdown Data by Application
5.1 Global Biopharmaceutical CMO Services Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biopharmaceutical CMO Services Market Size (2016-2027)
6.2 North America Biopharmaceutical CMO Services Market Size by Type
6.2.1 North America Biopharmaceutical CMO Services Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceutical CMO Services Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceutical CMO Services Market Size by Type (2016-2027)
6.3 North America Biopharmaceutical CMO Services Market Size by Application
6.3.1 North America Biopharmaceutical CMO Services Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceutical CMO Services Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceutical CMO Services Market Size by Application (2016-2027)
6.4 North America Biopharmaceutical CMO Services Market Size by Country
6.4.1 North America Biopharmaceutical CMO Services Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceutical CMO Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Biopharmaceutical CMO Services Market Size (2016-2027)
7.2 Europe Biopharmaceutical CMO Services Market Size by Type
7.2.1 Europe Biopharmaceutical CMO Services Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceutical CMO Services Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceutical CMO Services Market Size by Type (2016-2027)
7.3 Europe Biopharmaceutical CMO Services Market Size by Application
7.3.1 Europe Biopharmaceutical CMO Services Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceutical CMO Services Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceutical CMO Services Market Size by Application (2016-2027)
7.4 Europe Biopharmaceutical CMO Services Market Size by Country
7.4.1 Europe Biopharmaceutical CMO Services Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceutical CMO Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO Services Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical CMO Services Market Size (2016-2027)
9.2 Latin America Biopharmaceutical CMO Services Market Size by Type
9.2.1 Latin America Biopharmaceutical CMO Services Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceutical CMO Services Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceutical CMO Services Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceutical CMO Services Market Size by Application
9.3.1 Latin America Biopharmaceutical CMO Services Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceutical CMO Services Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceutical CMO Services Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceutical CMO Services Market Size by Country
9.4.1 Latin America Biopharmaceutical CMO Services Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceutical CMO Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO Services Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biopharmaceutical CMO Services Introduction
11.1.4 Lonza Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.1.5 Lonza Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Biopharmaceutical CMO Services Introduction
11.2.4 Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 AGC Biologics
11.3.1 AGC Biologics Company Details
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics Biopharmaceutical CMO Services Introduction
11.3.4 AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.3.5 AGC Biologics Recent Development
11.4 Rentschler Biotechnologie
11.4.1 Rentschler Biotechnologie Company Details
11.4.2 Rentschler Biotechnologie Business Overview
11.4.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Introduction
11.4.4 Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.4.5 Rentschler Biotechnologie Recent Development
11.5 JRS Pharma
11.5.1 JRS Pharma Company Details
11.5.2 JRS Pharma Business Overview
11.5.3 JRS Pharma Biopharmaceutical CMO Services Introduction
11.5.4 JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.5.5 JRS Pharma Recent Development
11.6 Catalent
11.6.1 Catalent Company Details
11.6.2 Catalent Business Overview
11.6.3 Catalent Biopharmaceutical CMO Services Introduction
11.6.4 Catalent Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.6.5 Catalent Recent Development
11.7 Biomeva
11.7.1 Biomeva Company Details
11.7.2 Biomeva Business Overview
11.7.3 Biomeva Biopharmaceutical CMO Services Introduction
11.7.4 Biomeva Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.7.5 Biomeva Recent Development
11.8 Samsung BioLogics
11.8.1 Samsung BioLogics Company Details
11.8.2 Samsung BioLogics Business Overview
11.8.3 Samsung BioLogics Biopharmaceutical CMO Services Introduction
11.8.4 Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.8.5 Samsung BioLogics Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Biopharmaceutical CMO Services Introduction
11.9.4 AbbVie Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.9.5 AbbVie Recent Development
11.10 Binex
11.10.1 Binex Company Details
11.10.2 Binex Business Overview
11.10.3 Binex Biopharmaceutical CMO Services Introduction
11.10.4 Binex Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.10.5 Binex Recent Development
11.11 WuXi Biologics
11.11.1 WuXi Biologics Company Details
11.11.2 WuXi Biologics Business Overview
11.11.3 WuXi Biologics Biopharmaceutical CMO Services Introduction
11.11.4 WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.11.5 WuXi Biologics Recent Development
11.12 PRA Health Sciences
11.12.1 PRA Health Sciences Company Details
11.12.2 PRA Health Sciences Business Overview
11.12.3 PRA Health Sciences Biopharmaceutical CMO Services Introduction
11.12.4 PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.12.5 PRA Health Sciences Recent Development
11.13 ProBioGen
11.13.1 ProBioGen Company Details
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Biopharmaceutical CMO Services Introduction
11.13.4 ProBioGen Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.13.5 ProBioGen Recent Development
11.14 KBI Biopharma
11.14.1 KBI Biopharma Company Details
11.14.2 KBI Biopharma Business Overview
11.14.3 KBI Biopharma Biopharmaceutical CMO Services Introduction
11.14.4 KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2016-2021)
11.14.5 KBI Biopharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biopharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics Manufacturing
Table 3. Key Players of Biosimilars Manufacturing
Table 4. Key Players of Others
Table 5. Global Biopharmaceutical CMO Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biopharmaceutical CMO Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biopharmaceutical CMO Services Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Biopharmaceutical CMO Services Market Share by Regions (2016-2021)
Table 9. Global Biopharmaceutical CMO Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Biopharmaceutical CMO Services Market Share by Regions (2022-2027)
Table 11. Biopharmaceutical CMO Services Market Trends
Table 12. Biopharmaceutical CMO Services Market Drivers
Table 13. Biopharmaceutical CMO Services Market Challenges
Table 14. Biopharmaceutical CMO Services Market Restraints
Table 15. Global Biopharmaceutical CMO Services Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Biopharmaceutical CMO Services Market Share by Players (2016-2021)
Table 17. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO Services as of 2020)
Table 18. Ranking of Global Top Biopharmaceutical CMO Services Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Biopharmaceutical CMO Services Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biopharmaceutical CMO Services Product Solution and Service
Table 22. Date of Enter into Biopharmaceutical CMO Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2016-2021)
Table 26. Global Biopharmaceutical CMO Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Biopharmaceutical CMO Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2016-2021)
Table 30. Global Biopharmaceutical CMO Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Biopharmaceutical CMO Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Biopharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Biopharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Biopharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Biopharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Biopharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Biopharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Biopharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Biopharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Biopharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Biopharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Biopharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Biopharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Biopharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Biopharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Biopharmaceutical CMO Services Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Biopharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Biopharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Biopharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Biopharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Biopharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Biopharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Biopharmaceutical CMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Biopharmaceutical CMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Biopharmaceutical CMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 62. Lonza Company Details
Table 63. Lonza Business Overview
Table 64. Lonza Biopharmaceutical CMO Services Product
Table 65. Lonza Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 66. Lonza Recent Development
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Biopharmaceutical CMO Services Product
Table 70. Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Development
Table 72. AGC Biologics Company Details
Table 73. AGC Biologics Business Overview
Table 74. AGC Biologics Biopharmaceutical CMO Services Product
Table 75. AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 76. AGC Biologics Recent Development
Table 77. Rentschler Biotechnologie Company Details
Table 78. Rentschler Biotechnologie Business Overview
Table 79. Rentschler Biotechnologie Biopharmaceutical CMO Services Product
Table 80. Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 81. Rentschler Biotechnologie Recent Development
Table 82. JRS Pharma Company Details
Table 83. JRS Pharma Business Overview
Table 84. JRS Pharma Biopharmaceutical CMO Services Product
Table 85. JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 86. JRS Pharma Recent Development
Table 87. Catalent Company Details
Table 88. Catalent Business Overview
Table 89. Catalent Biopharmaceutical CMO Services Product
Table 90. Catalent Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 91. Catalent Recent Development
Table 92. Biomeva Company Details
Table 93. Biomeva Business Overview
Table 94. Biomeva Biopharmaceutical CMO Services Product
Table 95. Biomeva Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 96. Biomeva Recent Development
Table 97. Samsung BioLogics Company Details
Table 98. Samsung BioLogics Business Overview
Table 99. Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 100. Samsung BioLogics Recent Development
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Biopharmaceutical CMO Services Product
Table 104. AbbVie Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 105. AbbVie Recent Development
Table 106. Binex Company Details
Table 107. Binex Business Overview
Table 108. Binex Biopharmaceutical CMO Services Product
Table 109. Binex Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 110. Binex Recent Development
Table 111. WuXi Biologics Company Details
Table 112. WuXi Biologics Business Overview
Table 113. WuXi Biologics Biopharmaceutical CMO Services Product
Table 114. WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 115. WuXi Biologics Recent Development
Table 116. PRA Health Sciences Company Details
Table 117. PRA Health Sciences Business Overview
Table 118. PRA Health Sciences Biopharmaceutical CMO Services Product
Table 119. PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 120. PRA Health Sciences Recent Development
Table 121. ProBioGen Company Details
Table 122. ProBioGen Business Overview
Table 123. ProBioGen Biopharmaceutical CMO Services Product
Table 124. ProBioGen Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 125. ProBioGen Recent Development
Table 126. KBI Biopharma Company Details
Table 127. KBI Biopharma Business Overview
Table 128. KBI Biopharma Biopharmaceutical CMO Services Product
Table 129. KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2016-2021) & (US$ Million)
Table 130. KBI Biopharma Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO Services Market Share by Type: 2020 VS 2027
Figure 2. Biologics Manufacturing Features
Figure 3. Biosimilars Manufacturing Features
Figure 4. Others Features
Figure 5. Global Biopharmaceutical CMO Services Market Share by Application: 2020 VS 2027
Figure 6. Clinical Manufacturing Case Studies
Figure 7. Commercial Manufacturing Case Studies
Figure 8. Others Case Studies
Figure 9. Biopharmaceutical CMO Services Report Years Considered
Figure 10. Global Biopharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biopharmaceutical CMO Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biopharmaceutical CMO Services Market Share by Regions: 2020 VS 2027
Figure 13. Global Biopharmaceutical CMO Services Market Share by Regions (2022-2027)
Figure 14. Global Biopharmaceutical CMO Services Market Share by Players in 2020
Figure 15. Global Top Biopharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO Services as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO Services Revenue in 2020
Figure 17. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2016-2021)
Figure 18. Global Biopharmaceutical CMO Services Revenue Market Share by Type (2022-2027)
Figure 19. North America Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biopharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 21. North America Biopharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 22. North America Biopharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 23. United States Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biopharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 27. Europe Biopharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 28. Europe Biopharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 29. Germany Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biopharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biopharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biopharmaceutical CMO Services Market Share by Region (2016-2027)
Figure 39. China Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biopharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 47. Latin America Biopharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 48. Latin America Biopharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 49. Mexico Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biopharmaceutical CMO Services Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Biopharmaceutical CMO Services Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Biopharmaceutical CMO Services Market Share by Country (2016-2027)
Figure 55. Turkey Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Biopharmaceutical CMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Lonza Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 60. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 61. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 62. JRS Pharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 63. Catalent Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 64. Biomeva Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 65. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 67. Binex Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 68. WuXi Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 69. PRA Health Sciences Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 70. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 71. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…- 世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
- 世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing(BCMO) Market The global Biopharmaceutical Contract Manufacturing(BCMO) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accura…
- 世界のバイオ医薬品CMO・CRO市場規模・現状・予測（2021年-2027年） Key factors that are driving the biopharmaceutical CMO & CRO market growth include the rise in investment by CMOs for capacity expansion, the commercial success of biopharmaceuticals, and consequent increase in demand for biopharmaceuticals, and robust biopharmaceuticals pipeline Market Analysis and…
- 世界のウイルスベクター製造市場規模・現状・予測（2021年-2027年） Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells. Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors bas…